A 4924
Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill, the "End-Stage Kidney Disease Prevention and Innovation Act," establishes a research center within the New Jersey Department of Health to study rare kidney diseases. It appropriates $10 million to fund this center and support research into causes, diagnosis, treatment, and prevention of these diseases, with a focus on underserved communities and genetic testing. The bill also mandates a study on testing methods, preventative care, and treatment patterns for rare kidney disease.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Kenyatta Stewart
Shanique Speight
Cosponsor
Vincent Kearney
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.